Crossmark

Targeting senescence

Crossref DOI link: https://doi.org/10.1038/s41591-018-0141-4

Published Online: 2018-08-06

Published Print: 2018-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Serrano, Manuel

Barzilai, Nir
License Information

Text and Data Mining valid from 2018-08-01
More Information

Article History

First Online: 6 August 2018

Competing interests

: M.S. is the founder and a shareholder of Senolytic Therapeutics, Inc. (United States) and Senolytic Therapeutics, S.L. (Spain). N.B. is the founder of CohBar Inc. and a medical advisor to Life Biosciences.